» Articles » PMID: 11579095

The Proto-oncoprotein Brx Activates Estrogen Receptor Beta by a P38 Mitogen-activated Protein Kinase Pathway

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Oct 2
PMID 11579095
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The estrogen receptors (ERs) are ligand-inducible transcription factors that play key roles in the control of growth and differentiation in reproductive tissues. We showed that the novel Dbl family proto-oncoprotein Brx enhances ligand-dependent activity of ERalpha via a Cdc42-dependent pathway. Brx also significantly enhances ligand-dependent activity of ERbeta. This enhancement is not affected by inhibition of p44/42 mitogen-activated protein kinase (MAPK) activation by PD98059. However, addition of the p38 MAPK inhibitor SB202190 abrogates the enhancement of ERbeta activity by Brx, showing that p38 MAPK activity is required for the enhancement of ERbeta function by Brx. In COS-7 cells, transfection of Brx leads to activation of endogenous p38 MAPK activity. Co-expression of the beta2 isoform of human p38 MAPK and a constitutively active form of the p38 MAPK kinase MKK6 (MKK6-EE) synergistically augments ligand-dependent activity of ERbeta. Our findings suggest that p38 MAPKs may be important regulators of ERbeta activity.

Citing Articles

Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases.

Aswani B, Hegde M, Vishwa R, AlQahtani M, Abbas M, Almubarak H Mil Med Res. 2024; 11(1):67.

PMID: 39327610 PMC: 11426102. DOI: 10.1186/s40779-024-00564-1.


TNFR1/p38αMAPK signaling in Nex + supraspinal neurons regulates estrogen-dependent chronic neuropathic pain.

Swanson K, Nguyen K, Gupta S, Ricard J, Bethea J Brain Behav Immun. 2024; 119:261-271.

PMID: 38570102 PMC: 11162907. DOI: 10.1016/j.bbi.2024.03.050.


AKAP13 Enhances CREB1 Activation by FSH in Granulosa Cells.

Cayton Vaught K, Hazimeh D, Carter A, Devine K, Maher J, Maguire M Reprod Sci. 2022; 30(5):1528-1539.

PMID: 36401072 PMC: 10164136. DOI: 10.1007/s43032-022-01097-5.


The role of Hippo pathway signaling and A-kinase anchoring protein 13 in primordial follicle activation and inhibition.

Maher J, Islam M, Yin O, Brennan J, Gough E, Driggers P F S Sci. 2022; 3(2):118-129.

PMID: 35560009 PMC: 11096729. DOI: 10.1016/j.xfss.2022.03.002.


Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor.

Mal R, Magner A, David J, Datta J, Vallabhaneni M, Kassem M Front Oncol. 2020; 10:587386.

PMID: 33194742 PMC: 7645238. DOI: 10.3389/fonc.2020.587386.


References
1.
Su L, Knoblauch R, Garabedian M . Rho GTPases as modulators of the estrogen receptor transcriptional response. J Biol Chem. 2000; 276(5):3231-7. DOI: 10.1074/jbc.M005547200. View

2.
Cerione R, Zheng Y . The Dbl family of oncogenes. Curr Opin Cell Biol. 1996; 8(2):216-22. DOI: 10.1016/s0955-0674(96)80068-8. View

3.
Rutqvist L, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N . Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst. 1995; 87(9):645-51. DOI: 10.1093/jnci/87.9.645. View

4.
Mosselman S, Polman J, Dijkema R . ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996; 392(1):49-53. DOI: 10.1016/0014-5793(96)00782-x. View

5.
Kjoller L, Hall A . Signaling to Rho GTPases. Exp Cell Res. 1999; 253(1):166-79. DOI: 10.1006/excr.1999.4674. View